Barcelona Clinical Trials Platform

Treballem per l’excel·lència en investigació i recerca

An iniciative by

  • Generalitat de Catalunya. Departament de Salut
  • Biocat

Gemma Estrada: "We want to position Catalonia at the forefront of clinical trials in Europe"

07/16/2015

The BCTP aims to be a key tool for coordinating Catalan hospitals that do clinical research

The BCTP aims to be a key tool for coordinating Catalan hospitals that do clinical research

The Barcelona Clinical Trials Platform (BCTP) has been created with the clear, powerful aim of becoming a key tool for coordinating Catalan hospitals that do clinical research in order to act as a single metacenter that is a gateway to 5 million patients.

BCTP Director Gemma Estrada, in an interview with the Barcelona Science Park (PCB), highlighted that this ambitious project aims to go one step further and “compete with leading international institutes in their effort to attract clinical research projects, positioning Catalonia at the forefront of clinical trials in Europe.” This metacenter that the Platform will become not only seeks to boost Catalonia’s international projection but also “to avoid the scattering of resources through the establishment of interest partnerships and increase the critical mass of researchers and patients,” says Estrada.

Under the BCTP umbrella, the collective international visibility of the institutions will increase. This has been seen in other regions of Europe, like Scotland with its group of university hospitals, and the world, like all the Harvard University hospitals joining forces in Boston (United States). England has also created the National Institute for Health Research - Clinical Research Network, a platform that brings together 15 regional platforms like the BCTP and in its 6 years of history has recruited roughly 100,000 patients. These international examples, says Estrada, demonstrate the BCTP’s potential, as “in the last 3 years, we have recruited an average of 4,500 patients per year,” which she says is a good number.

The project is now done with the conceptualization phase and is “at the point of pulling up resources, both public and private, to start working.” The BCTP aims to make talent and technology in research institutes available for clinical trials and to integrate them into medical practice through personalized medicine. This has led to a BCTP pilot program in precision oncology, GENPRECIS.CAT, "which involves molecular characterization of all patients diagnosed with certain cancers to optimize their allocation to available therapies, whether marketed or experimental drugs,” explains Gemma Estrada.

Read the full interview here.

Share: